使用血清组C脑膜炎球菌联合疫苗进行大规模免疫运动的有效性
Philippe De Wals1, Geneviève Deceuninck, Nicole Boulianne
1Quebec National Public Health Institute and Department of Preventive and Social Medicine, Laval University, Quebec City, Quebec. Philippe.De.Wals@ssss.gouv.qc.ca
JAMA
|November 25, 2004
概括
一种新的脑膜炎球菌联合疫苗被证明是非常有效的,在控制血清组C疾病爆发方面达到96.8%的有效性. 这种联合疫苗在广泛的年龄范围内提供短期保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
背景情况:
- 传统的脑膜炎球菌多糖体疫苗的疗效有限.
- 蛋白质多糖联合疫苗需要现场评估其有效性.
研究的目的:
- 为了评估血清组C结合性脑膜炎球菌疫苗的有效性.
- 在活跃的疾病爆发环境中评估疫苗的性能.
主要方法:
- 基于人口的观察性研究分析了侵入性血清组C脑膜炎球菌病例 (1996-2002).
- 2001年进行了一次大规模免疫接种活动,以控制新兴的流行病.
- 疫苗接种者与未接种者的疾病发病率比较,疫苗接种前和疫苗接种后.
主要成果:
- 在2个月至20岁的个体中实现了82.1%的疫苗接种覆盖率.
- 观察到运动后血清组C疾病发病率显著下降 (每百万分之一7.8至3.6).
- 疫苗的有效性高达96.8%,其他血清组没有增加.
结论:
- 联合疫苗有效控制了血清组C脑膜炎球菌疾病流行病.
- 该疫苗在广泛的年龄人口中提供了显著的短期保护.
- 强调联合疫苗在控制脑膜炎球菌疫情中的价值.
相关概念视频
Vaccinations
Overview
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...


